Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome

  • Natalia Zeber-Lubecka
  • , Maria Kulecka
  • , Filip Ambrozkiewicz
  • , Agnieszka Paziewska
  • , Krzysztof Goryca
  • , Jakub Karczmarski
  • , Tymon Rubel
  • , Wojciech Wojtowicz
  • , Piotr Mlynarz
  • , Lukasz Marczak
  • , Roman Tomecki
  • , Michal Mikula
  • , Jerzy Ostrowski

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science